John Fletcher

Mr. John Fletcher is on the Board of Directors at Asian Cleveland Ltd., Begrand Resources Ltd., EPC China, Inc., FF Financial Services Ltd., Huge Seas Ltd., Inteq Ltd., Somerley Australia Ltd., Somerley China Associates Ltd., Somerley Group Ltd., Somerley Investment Consulting (Shanghai) Ltd., Somerley Ltd., Somerley Singapore Pte Ltd.
and Sword Events Ltd.
Mr. Fletcher is a current or past board member for many companies, including Spectranetics, Axcelis, AutoImmune, GlycoFi, NMT Medical, Quick Study Radiology, Alimed, Fischer Imaging and Panacos Pharmaceuticals.
He also is, or has been, a board member of many non-profit organizations including Board of Overseers of Beth Israel Deaconess Hospital, The Cardiology Council, Board of Overseers of Children's Hospital of Boston, the Board of Advisors of the Boston University Photonics Center, the Whitehead Institute at MIT, the Masters in Engineering Management of Thayer School of Engineering and the Tuck School of Business at Dartmouth College, and the School of Government and Business at George Washington University.
Mr. Fletcher is Managing Partner of Fletcher Spaght Ventures, a venture capital fund.
He is also Founder and CEO of Fletcher Spaght, Inc., a consulting firm that provides growth-focused strategy assistance to client companies.
He has more than 30 years’ experience providing strategy and financing assistance to companies seeking to maximize the value of their innovation.
Prior to launching FSI in 1983, Mr. Fletcher was a Senior Manager at The Boston Consulting Group.
Previously, he was a Ph.D.
candidate and instructor in international business at The Wharton School, University of Pennsylvania.
Prior to Wharton, he was a Captain and jet pilot in the U.S.
Air Force.
He holds an M.B.A.
from Southern Illinois University and a B.B.A.
from George Washington University.